Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,979 | -56,828 | -31,385 | -51,660 | -89,945 |
| Depreciation Amortization | -872 | 14,968 | 4,203 | 916 | 1,222 |
| Income taxes - deferred | -4,963 | N/A | -248 | -284 | N/A |
| Accounts payable and accrued liabilities | -940 | 927 | -288 | -5,943 | 1,356 |
| Other Working Capital | 12,843 | -484 | 1,977 | -9,829 | -4,261 |
| Other Operating Activity | 36,486 | 9,513 | 7,449 | 22,762 | 28,696 |
| Operating Cash Flow | $-41,425 | $-31,904 | $-18,292 | $-44,038 | $-62,932 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,997 | 111,727 | N/A | 82,493 | N/A |
| PPE Investments | -352 | -257 | -70 | -63 | -180 |
| Net Acquisitions | N/A | N/A | -2,116 | 10,593 | N/A |
| Purchase Of Investment | -34,418 | -89,562 | -113,781 | -75,021 | -38,789 |
| Sale Of Investment | N/A | N/A | 111,209 | N/A | 97,921 |
| Other Investing Activity | 0 | 0 | -1,000 | 0 | 0 |
| Investing Cash Flow | $23,227 | $21,908 | $-5,758 | $18,002 | $58,952 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -6 | -49 | N/A |
| Common Stock Issued | 17,909 | 225 | 149 | 756 | 6,808 |
| Other Financing Activity | 0 | -5,000 | 0 | 0 | 0 |
| Financing Cash Flow | $17,909 | $-4,775 | $143 | $707 | $6,808 |
| Exchange Rate Effect | -114 | 231 | 80 | 184 | 55 |
| Beginning Cash Position | 6,212 | 20,752 | 44,579 | 69,724 | 66,841 |
| End Cash Position | 5,809 | 6,212 | 20,752 | 44,579 | 69,724 |
| Net Cash Flow | $-403 | $-14,540 | $-23,827 | $-25,145 | $2,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,425 | -31,904 | -18,292 | -44,038 | -62,932 |
| Capital Expenditure | -352 | -257 | -160 | -133 | -180 |
| Free Cash Flow | -41,777 | -32,161 | -18,452 | -44,171 | -63,112 |